NEW ENTERPRISE ASSOCIATES 13 LP

SGMT

NEW ENTERPRISE ASSOCIATES 13 LP serves as 10% Owner at Sagimet Biosciences Inc. (SGMT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$480.0K

Total Sells

1 trades

$10.6K

Net Position

Net Buyer

$469.4K

Companies Traded

SGMT

Active Period

Jul 2023

2 total trades

Most Recent

Buy SGMT

Jul 20, 2023 · $480.0K

NEW ENTERPRISE ASSOCIATES 13 LP's Insider Trading at Sagimet Biosciences Inc. (SGMT)

Buys

1 · $480.0K

Sells

1 · $10.6K

Total Shares Bought

30,000

Total Shares Sold

662

SGMT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 20, 2023	Buy	30,000	$16.00	$480.0K	3,850,275
Jul 20, 2023	Sell	662	$16.00	$10.6K	3,820,275

Related Insiders

Thierry Chauche

officer: Chief Financial Officer

SGMTSell · Feb 12, 2026

David Happel

President & CEO

SGMTSell · Feb 12, 2026

Eduardo Bruno Martins

officer: Chief Medical Officer

SGMTSell · Feb 12, 2026

Elizabeth Rozek

officer: Chief Legal & Admin. Officer

SGMTSell · Feb 12, 2026

George Kemble

Executive Chairman

SGMTSell · Nov 21, 2025

Explore More Insider Trading Data

SGMT Insider Trading Activity

View all insider trades at Sagimet Biosciences Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity